BIOSTEMI Extended Survival

CompletedOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

October 28, 2023

Conditions
Coronary Artery DiseaseAcute Coronary Syndrome
Trial Locations (10)

1011

Lausanne University Hospitals, Lausanne

1205

Geneva University Hospitals, Geneva

1700

Hôpital Cantonal de Fribourg, Fribourg

1951

Spital Wallis, Sion

3010

Inselspital, Bern University Hospital, Bern

4031

Basel University Hospital, Basel

5001

Kantonsspital Aarau, Aarau

6000

Kantonsspital Luzern, Lucerne

8063

Triemli Hospital, Zurich

9007

Kantonsspital St.Gallen, Sankt Gallen

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

University Hospital, Geneva

OTHER

NCT05484310 - BIOSTEMI Extended Survival | Biotech Hunter | Biotech Hunter